UNICA IRIS Institutional Research Information System

LA NASA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 287.287
NA - Nord America 23.226
AS - Asia 11.715
SA - Sud America 1.896
AF - Africa 326
OC - Oceania 106
Continente sconosciuto - Info sul continente non disponibili 8
Totale 324.564
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 276.699
US - Stati Uniti d'America 22.831
SG - Singapore 4.382
CN - Cina 3.882
NL - Olanda 3.324
UA - Ucraina 1.851
SE - Svezia 1.504
BR - Brasile 1.455
VN - Vietnam 1.043
FI - Finlandia 912
DE - Germania 867
GB - Regno Unito 739
FR - Francia 650
HK - Hong Kong 467
IN - India 399
KR - Corea 320
CA - Canada 228
JP - Giappone 163
AR - Argentina 156
IQ - Iraq 142
BD - Bangladesh 135
MX - Messico 112
TR - Turchia 111
PL - Polonia 105
RU - Federazione Russa 101
ZA - Sudafrica 99
IE - Irlanda 97
AU - Australia 92
PK - Pakistan 88
AT - Austria 87
ES - Italia 71
ID - Indonesia 69
IR - Iran 69
EC - Ecuador 68
SA - Arabia Saudita 61
CO - Colombia 54
MA - Marocco 50
MY - Malesia 49
EG - Egitto 47
VE - Venezuela 46
UZ - Uzbekistan 44
PH - Filippine 43
BE - Belgio 38
CL - Cile 34
CZ - Repubblica Ceca 33
LT - Lituania 28
IL - Israele 27
CH - Svizzera 25
JO - Giordania 25
PY - Paraguay 24
AE - Emirati Arabi Uniti 23
DK - Danimarca 22
RO - Romania 22
TH - Thailandia 22
ET - Etiopia 20
KE - Kenya 20
KZ - Kazakistan 20
PE - Perù 20
NP - Nepal 17
TN - Tunisia 17
UY - Uruguay 17
TW - Taiwan 16
AZ - Azerbaigian 15
OM - Oman 14
PT - Portogallo 14
DZ - Algeria 13
HU - Ungheria 13
MU - Mauritius 13
NZ - Nuova Zelanda 12
BO - Bolivia 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
IS - Islanda 10
JM - Giamaica 10
LB - Libano 10
SY - Repubblica araba siriana 9
EU - Europa 8
GE - Georgia 8
SD - Sudan 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
BG - Bulgaria 7
BY - Bielorussia 7
GR - Grecia 7
NO - Norvegia 7
TZ - Tanzania 7
GY - Guiana 6
JE - Jersey 6
PA - Panama 6
RS - Serbia 6
SN - Senegal 6
AO - Angola 5
CY - Cipro 5
HN - Honduras 5
PR - Porto Rico 5
QA - Qatar 5
AM - Armenia 4
CR - Costa Rica 4
HR - Croazia 4
KG - Kirghizistan 4
Totale 324.492
Salva come PNG Salva come JPEG
Città #
Cagliari 266.776
Uta 7.753
Amsterdam 3.196
Singapore 2.113
Ashburn 2.036
Fairfield 1.949
Woodbridge 1.623
Chandler 1.471
San Jose 1.321
Boardman 1.238
Dallas 1.143
Houston 1.055
Ann Arbor 1.015
Jacksonville 946
Wilmington 854
Nyköping 847
Seattle 759
Beijing 701
Cambridge 668
Helsinki 591
Los Angeles 501
New York 477
Hefei 406
Hong Kong 394
Lauterbourg 328
Nanjing 316
Boston 304
Ho Chi Minh City 303
The Dalles 263
Santa Clara 250
Seoul 246
Council Bluffs 233
Dearborn 211
Milan 208
Hanoi 204
Munich 198
Shanghai 185
Buffalo 172
Rome 152
Dong Ket 150
San Diego 141
São Paulo 135
Orem 105
Shenyang 103
Guangzhou 101
Hebei 90
Changsha 89
Tokyo 88
Toronto 87
Nanchang 83
Tianjin 82
Redondo Beach 81
Frankfurt am Main 80
Verona 79
London 77
Redwood City 73
Atlanta 71
Warsaw 70
Nuremberg 69
Rio de Janeiro 69
Jiaxing 65
Chicago 64
Orange 61
Baghdad 59
Dublin 59
Menlo Park 59
Washington 58
Pune 56
Montreal 52
Mountain View 51
Phoenix 51
Vienna 51
Norwalk 50
Sassari 49
Brooklyn 48
Chennai 48
Denver 47
Da Nang 45
Stockholm 40
Tashkent 40
Jinan 38
Johannesburg 37
Sydney 37
Incheon 36
Mumbai 36
Brussels 35
Haiphong 34
Manchester 34
Ningbo 32
Wuhan 32
San Francisco 29
Ankara 28
Auburn Hills 28
New Delhi 28
Turku 28
Brasília 27
Istanbul 27
Redmond 27
Zhengzhou 27
Falls Church 25
Totale 307.007
Salva come PNG Salva come JPEG
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.563
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.584
The impact of NOD2/CARD15 SNPs on the severe gastrointestinal GVHD following allogeneic Stem Cell Transplantation in Sardinia population 3.436
Comparison Between an Artificial Neural Network and Logistic Regression in Predicting Long Term Kidney Transplantation Outcome 3.427
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.396
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma 3.363
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.343
What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics 3.317
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.313
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients 3.306
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia 3.231
Reassessing the approach to informed consent: The case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 3.044
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.910
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2.825
Ruolo del trapianto allogenico nelle talassemie 2.768
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma 2.745
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.719
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 2.607
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.602
In vitro ovine articular chondrocyte proliferation: experiments and modelling 2.545
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 2.521
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia 2.251
Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells 2.246
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.241
Health related quality of life in patients with onco-hematological diseases 2.234
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 2.191
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.165
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.121
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 2.116
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.108
Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma 2.055
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 1.983
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.967
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia 1.959
Ruxolitinib therapy and telomere length in myelofibrosis 1.956
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 1.949
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life 1.937
Experimental analysis and modeling of in vitro mesenchymal stem cells proliferation 1.917
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.878
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 1.875
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 1.834
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis 1.833
THE HLA-G 14-BP POLYMORPHISM IS AN INDEPENDENT GENETIC RISK MARKER OF LONG-TERM KIDNEY TRANSPLANTATION OUTCOME 1.806
null 1.759
The human leukocyte antigen-g 14-bp polymorphism is an independent genetic risk marker of long-term kidney transplantation outcome 1.754
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.743
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting 1.675
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.610
Acute basophilic leukemia with U2AF1 mutation 1.593
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.581
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.568
Unrelated bone marrow transplantation in Thalassemia. The experience of the Italian Bone Marrow transplant Group (GITMO) 1.552
T cell tyrosine phosphorylation response to transient redox stress 1.549
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 1.534
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 1.529
Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis 1.528
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.496
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.484
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report 1.466
Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia 1.464
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party 1.459
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 1.456
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation 1.446
Perls stain grade in bone marrow aspirate correlates with overall survival in low-risk myelodysplastic patients 1.443
Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors 1.439
null 1.419
Resolution of capillary leak syndrome by extracorporeal membrane oxygenation 1.402
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1.399
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation 1.366
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study 1.364
Improved outcomes With retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 1.362
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.336
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm 1.332
A simulated case of chronic myeloid leukemia: the growing risk of Munchausen’s Syndrome by internet 1.319
Immunological deregulation in classic hodgkin lymphoma 1.315
Rectal involvement in pre-early T acute lymphoblastic leukemia 1.303
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated donor hematopoietic stem cell transplantation in thalassemia patients 1.302
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 1.295
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 1.278
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia 1.230
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.226
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 1.222
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.217
The role of inhibitory KIR 2DL5 in the outcome of autologous hematopoietic stem cell transplantation for multiple myeloma 1.215
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.213
Multiple myeloma treatment in real-world clinical practice: Results of a prospective, multinational, noninterventional study 1.206
Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial 1.197
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 1.197
Stem cell transplantation for congenital dyserythropoietic anemia. An analysis from the European society for blood and marrow transplantation 1.194
Immunohistochemical findings in the lungs of COVID-19 subjects: Evidence of surfactant dysregulation 1.191
Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development 1.182
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation: a crystal ball to foresee the future? 1.166
Dasatinib first-line: multicentric Italian experience outside clinical trials 1.163
Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial 1.162
null 1.138
null 1.128
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated haematopoietic stem cell transplantation 1.126
null 1.110
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity 1.097
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.084
Totale 187.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 461.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 461.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.941 0 0 0 0 0 0 0 0 0 4.260 3.424 2.257
2021/202217.937 1.650 1.598 760 1.108 1.369 1.078 857 1.108 1.518 2.163 2.377 2.351
2022/202325.815 2.001 2.970 2.705 1.991 2.030 2.703 1.279 3.292 1.629 1.580 2.425 1.210
2023/202429.541 1.598 1.200 1.519 2.189 2.610 4.937 3.738 2.052 1.522 2.385 2.983 2.808
2024/202558.229 9.818 10.782 9.877 6.931 3.620 6.636 3.175 487 1.063 3.964 829 1.047
2025/202619.810 1.362 955 2.691 1.967 1.543 1.418 5.298 891 1.644 2.041 0 0
Totale 325.649